Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,069
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Boston MA, South Portland ME, East Syracuse NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Boston MA, New York NY, Toronto, Cleveland OH,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase3, Recruiting
Observational Study Protocol: LIVER-R
for
Hepatobiliary Cancers
Location: Boston MA, White Plains NY, Bethlehem PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06252753
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Boston MA, Stony Brook NY, Montreal, Trois-Rivieres,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06106945
Phase1, Phase2, Recruiting
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
for
Advanced Solid Malignancies
Location: Boston MA, New York NY, Chicago IL, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05417594
Phase1, Phase2, Recruiting
New
Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
for
Colorectal Cancer
Location: Boston MA
Sponsor: Harvard University
Sex: All
Age: 50 - 70+
Code: NCT01032746
Recruiting
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
for
Major Depressive Disorder
Location: Boston MA, Orangeburg NY, New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 65
Code: NCT05573074
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
for
Pulmonary Circulation Diseases
Location: Boston MA, Baltimore MD, Charleston SC, Rochester MN,
Sponsor: Medical University of Graz
Sex: All
Age: 18+
Code: NCT03954574
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Valhalla NY, Roslyn NY, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Tolerability of 532 nm Laser Treatment of Port Wine Stains
for
Port-Wine Stain
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT05841628
Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, Baltimore MD, Myrtle Beach SC,
Sponsor: Acerand Therapeutics (Hong Kong) Limited
Sex: Male
Age: 18+
Code: NCT06801236
Phase1, Recruiting
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
for
Acromegaly
Location: Boston MA, Philadelphia PA, Cleveland OH, Columbus OH,
Sponsor: Debiopharm International SA
Sex: All
Age: 18+
Code: NCT06930625
Phase3, Recruiting
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Location: Boston MA, New Brunswick NJ, Chicago IL, Austin TX
Sponsor: Cellectis S.A.
Sex: All
Age: 18 - 70+
Code: NCT05607420
Phase1, Phase2, Recruiting
Star Matrix vs Autogenous Graft for Gingival Augmentation: Split-Mouth RCT